Centene sees FY24 adjusted EPS greater than $6.70, consensus $6.77

Sees FY24 revenue $142.5B-$145.5B, consensus $142.12B. Sees FY24 adjusted effective tax rate 24.3%-25.3%. Centene will host its investor day to outline its 2024 financial guidance as well as provide updates on its long-term strategic plan, designed to deliver long-term shareholder value. “We continue to execute against our strategic plan, positioning Centene to deliver strong, long-term earnings growth and create meaningful shareholder value. Looking to the year ahead, we see the opportunity to provide access to high-quality health care for more Americans by working every day to make healthcare affordable. Today, we are increasing our 2024 adjusted diluted EPS outlook to “greater than $6.70,” indicative of positive operational momentum and strong execution against our plan. While there is still work to do, we are proud of the significant progress made this year and are energized to continue demonstrating results in 2024,” said CEO of Centene, Sarah London.